Overview
John Minna is an Oncologist practicing medicine in Dallas, Texas.
Dr. Minna is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer (SCLC).
He is actively involved in clinical research, co-authoring 308 peer reviewed articles.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- POS
- PPO
Locations
5323 Harry Hines Blvd, Dallas, TX 75390
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
UT Southwestern-Bill And Rita Clements Advanced Medical Imaging Center
Farrukh Awan is a Hematologist and an Oncologist practicing medicine in Dallas, Texas. Dr. Awan is highly rated in 38 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Texas Oncology, P.A.
Dr. O'Shaughnessy is a Medical Oncologist that focuses on breast cancer prevention and treatment. She founded The School of Breast Oncology, a program providing a curriculum-based program focused exclusively on breast cancer clinical management. Dr. O'Shaughnessy attended medical school at Yale University School of Medicine in New Haven, CT. She then completed her Internal Medicine residency at Massachusetts General Hospital in Boston, MA and a Medical Oncology fellowship at National Cancer Institute in Bethesda, MD. She is co-chair of Breast Cancer Research, chair of Breast Cancer Prevention Research at Baylor Charles A. Sammons Cancer Center and a member of the Scientific Advisory Board for US Oncology Research Network. Dr. O'shaughnessy is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, PIK3CA-Related Overgrowth Spectrum, Inflammatory Breast Cancer, and Tissue Biopsy. Dr. O'shaughnessy is board certified in Medical Oncology- American Board Of Internal Medicine, Medical Oncology- American Board Of Internal Med/Medical Oncology, Internal Medicine- American Board Of Internal Med, and Internal Medicine- American Board Of Internal Medicine. Dr. O'shaughnessy is currently accepting new patients.
Office
Hans Hammers is an Oncologist practicing medicine in Dallas, Texas. Dr. Hammers is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Wilms Tumor, Nephrectomy, and Thrombectomy.
Frequently Asked Questions about Dr. John D. Minna
How do I make an appointment with Dr. John D. Minna?
You can book an appointment with Dr. John D. Minna by calling their office at 214-648-4180. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. John D. Minna a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. John D. Minna is classified as an Elite expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. John D. Minna specialize in?
While Dr. John D. Minna is a Oncology, they have specific expertise in Lung Cancer, Lung Adenocarcinoma, and Non-Small Cell Lung Cancer (NSCLC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. John D. Minna participate in research or clinical trials?
Yes. Dr. John D. Minna has published 308 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. John D. Minna's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. John D. Minna accept my insurance?
Dr. John D. Minna accepts most major insurance plans, including Aetna and Health Care Services Corporation. We recommend calling the office directly at 214-648-4180 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Lung AdenocarcinomaDr. Minna isElite. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Minna isElite. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer (SCLC)
- Distinguished
- EGFR Positive Lung CancerDr. Minna isDistinguished. Learn about EGFR Positive Lung Cancer.
- Advanced
- Neuroendocrine TumorDr. Minna isAdvanced. Learn about Neuroendocrine Tumor.
- Squamous Cell Lung CarcinomaDr. Minna isAdvanced. Learn about Squamous Cell Lung Carcinoma.
- Experienced
- Breast CancerDr. Minna isExperienced. Learn about Breast Cancer.
- LeukemiaDr. Minna isExperienced. Learn about Leukemia.
- MesotheliomaDr. Minna isExperienced. Learn about Mesothelioma.
- PIK3CA-Related Overgrowth SpectrumDr. Minna isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.
- RetinoblastomaDr. Minna isExperienced. Learn about Retinoblastoma.
- Trophoblastic Tumor Placental SiteDr. Minna isExperienced. Learn about Trophoblastic Tumor Placental Site.